Stay updated with breaking news from Johnm Leonard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report)’s stock price traded up 11.3% during trading on Tuesday . The company traded as high as $31.13 and last traded at $30.79. 2,174,127 shares changed hands during trading, an increase of 39% from the average session volume of 1,563,047 shares. The stock had previously closed at $27.66. […]
Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) issued its earnings results on Thursday. The company reported ($1.46) earnings per share for the quarter, topping the consensus estimate of ($1.47) by $0.01, Briefing.com reports. Intellia Therapeutics had a negative return on equity of 43.31% and a negative net margin of 893.34%. The business had revenue of […]
Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) posted its earnings results on Thursday. The company reported ($1.46) EPS for the quarter, topping the consensus estimate of ($1.47) by $0.01, Briefing.com reports. Intellia Therapeutics had a negative net margin of 893.34% and a negative return on equity of 40.49%. The firm had revenue of ($1.92) million […]
Aigen Investment Management LP purchased a new stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 17,569 shares of the company’s stock, valued at approximately $556,000. Other institutional investors have also made changes to […]
Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) have earned an average rating of “Moderate Buy” from the eighteen research firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and fifteen have assigned a buy recommendation to the company. The average twelve-month […]